Document is current
Any future updates will be listed below
-
Authors
Hamid, Arsalan
Segar, Matthew W.
Bozkurt, Biykem
Santos-Gallego, Carlos
Nambi, Vijay
Butler, Javed
Hall, Michael E.
Fudim, Marat
- License Information
-
More Information
Article History
Accepted: 30 September 2024
First Online: 7 October 2024
Declarations
:
: Author disclosures: M.W.S. has received speaker fees from Merck and is on the advisory board for descendantsDNA. B.B. has served in consultation or advisory committee roles for Abiomed, American Regent, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Daiichi Sankyo, Johnson & Johnson, Hanger Institute, Merck, Occlutech, Regeneron, Roche, Sanofi, scPharmaceuticals, Vifor and Zoll/Respicardia, and is on the clinical event committees of Abbott Vascular and the data safety monitoring committees of Cardurion, Liva Nova, Novo Nordisk and Renovacor. C.SG. reported receiving grants from Merck and Robert Winn (Career Development Award) outside the submitted work. V. N. had stock with Abbott Labs (sold), stock with Insera therapeutics. J.B. has served as a consultant to Abbott, American Regent, Amgen, Applied Therapeutic, AskBio, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Cardiac Dimension, Cardiocell, Cardior, CSL Bearing, CVRx, Cytokinetics, Daxor, Edwards, Element Science, Faraday, Foundry, G3P, Innolife, Impulse Dynamics, Imbria, Inventiva, Ionis, Lexicon, Lilly, LivaNova, Janssen, Medtronic, Merck, Occlutech, Owkin, Novartis, Novo Nordisk, Pfizer, Pharmacosmos, Pharmain, Prolaio, Regeneron, Renibus, Roche, Salamandra, Sanofi, SC Pharma, Secretome, Sequana, SQ Innovation, Tenex, Tricog, Ultromics, Vifor, and Zoll. M.F. was supported by the NIH, Alleviant, Gradient, Reprieve, Sardocor, NIH and Doris Duke. He is a consultant/ownership interest in Abbott, Acorai, Ajax, Alio Health, Alleviant, Artha, Astellas, Audicor, AxonTherapies, Bodyguide, Bodyport, Boston Scientific, Broadview, Cadence, Cardiosense, Cardioflow, Clinical Accelerator, CVRx, Daxor, Edwards LifeSciences, Echosens, EKO, Endotronix, Feldschuh Foundation, Fire1, FutureCardia, Gradient, Hatteras, HemodynamiQ, Impulse Dynamics, ISHI, Lumina Health, Medtronic, NovoNordisk, NucleusRx, Omega, Orchestra, Parasym, Pharmacosmos, Presidio, Procyreon, Proton Intelligence, Puzzle, ReCor, Scirent, SCPharma, Shifamed, Splendo, Summacor, SyMap, Terumo, Vascular Dynamics, Vironix, Viscardia, Zoll. All other authors have no relevant disclosures.
